COVELLI, DANILA

COVELLI, DANILA  

Dipartimento di Scienze Cliniche e di Comunità  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Asymmetry indicates more severe and active disease in Graves’ orbitopathy : results from a prospective cross-sectional multicentre study 1-gen-2020 Covelli D.Muller I. + Article (author) -
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy 1-mag-2018 Colucci G.Covelli D.Muller I.Lucini L. + Article (author) -
The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience 1-lug-2020 Campi I.Covelli D.Fugazzola L.Persani L. + Article (author) -
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe graves' orbitopathy : a randomized controlled study 1-gen-2015 G. VannucchiI. CampiD. CovelliS. SimonettaL. PignataroP. Beck-Peccoz + Article (author) -
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy 1-gen-2021 Guia VannucchiIrene CampiDanila CovelliElisa LazzaroniLaura FugazzolaIlaria Muller + Article (author) -
Prevention of orbitopathy by oral or intravenous steroid prophylaxis in short duration Graves’ disease patients undergoing radioiodine ablation : A prospective randomized control trial study 1-dic-2019 Vannucchi G.Covelli D.Campi I.Curro N.Rodari M.Lazzaroni E. + Article (author) -
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy. 1-gen-2013 I. CampiG. VannucchiA. MinettiD. CovelliN. CurròR. RatigliaL. PignataroP. Beck-Peccoz + Article (author) -
Rituximab treatment in patients with active Graves' orbitopathy : effects on proinflammatory and humoral immune reactions 1-set-2010 G.M. VannucchiI. CampiM. BonomiD. CovelliN. CurròS. SimonettaL. PersaniP.L.M. Beck Peccoz + Article (author) -
SARS-CoV-2-related atypical thyroiditis 1-set-2020 Muller I.Cannavaro D.Covelli D.Mantovani G.Ferrante E.Orsi E.Cuzzocrea M.Bandera A.Lazzaroni E.Gori A.Arosio M. + Article (author) -
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy 1-mag-2012 G. VannucchiD. CovelliN. CurròA. MaffiniI. CampiP. BonaraL. PignataroR. RatigliaP. Beck Peccoz + Article (author) -
Small dose of rituximab for graves orbitopathy : new insights into the mechanism of action 1-gen-2012 G. VannucchiN. CurròP. BonaraD. CovelliL. PignataroR. RatigliaP. Beck-Peccoz + Article (author) -
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy 1-mag-2015 D. CovelliG. VannucchiI. CampiU. GianelliP. Beck-Peccoz + Article (author) -
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy 1-gen-2014 Curro N.Covelli D.Vannucchi G.Campi I.Pirola G.Simonetta S.Pignataro L.Beck-Peccoz P.Ratiglia R. + Article (author) -
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy 1-gen-2022 Campi, IreneVannucchi, GuiaMuller, IlariaLazzaroni, ElisaCovelli, DanilaPignataro, LorenzoFugazzola, LauraArosio, Maura + Article (author) -
Thyroid volume and serum calcitonin changes during pregnancy 1-lug-2017 Vannucchi GCovelli DVigo BFugazzola L. + Article (author) -